REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 135 filers reported holding REVOLUTION MEDICINES INC in Q4 2022. The put-call ratio across all filers is 0.32 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,119,324 | +4.3% | 40,438 | +0.8% | 0.00% | 0.0% |
| Q2 2023 | $1,073,183 | +48.9% | 40,119 | +20.6% | 0.00% | 0.0% |
| Q1 2023 | $720,672 | +6.0% | 33,272 | +16.6% | 0.00% | 0.0% |
| Q4 2022 | $679,894 | +22.4% | 28,543 | +1.3% | 0.00% | 0.0% |
| Q3 2022 | $555,572 | +21.8% | 28,173 | +20.3% | 0.00% | 0.0% |
| Q2 2022 | $456,000 | -23.6% | 23,413 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $597,000 | +1.4% | 23,413 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $589,000 | -8.3% | 23,413 | +0.4% | 0.00% | 0.0% |
| Q3 2021 | $642,000 | -13.2% | 23,326 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $740,000 | -12.7% | 23,326 | +26.3% | 0.00% | -50.0% |
| Q1 2021 | $848,000 | +27.5% | 18,473 | +10.0% | 0.00% | +100.0% |
| Q4 2020 | $665,000 | +49.4% | 16,797 | +31.4% | 0.00% | 0.0% |
| Q3 2020 | $445,000 | – | 12,779 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,524,031 | $151,966,000 | 28.85% |
| Ponoi II Management, LLC | 685,011 | $18,845,000 | 27.92% |
| Ponoi Management, LLC | 685,011 | $18,845,000 | 16.73% |
| Column Group LLC | 3,347,245 | $92,083,000 | 10.48% |
| TRV GP IV, LLC | 1,419,900 | $39,061,000 | 8.86% |
| Cormorant Asset Management, LP | 3,144,700 | $86,511,000 | 3.52% |
| Boxer Capital, LLC | 3,484,264 | $95,852,000 | 3.35% |
| BVF INC/IL | 2,485,049 | $68,364,000 | 2.67% |
| Casdin Capital, LLC | 2,800,000 | $77,028,000 | 1.92% |
| COMMODORE CAPITAL LP | 226,228 | $6,224,000 | 1.64% |